Glaukos Income Taxes 2014-2024 | GKOS

Glaukos annual/quarterly income taxes history and growth rate from 2014 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Glaukos income taxes for the quarter ending September 30, 2024 were $0.000B, a 378.38% increase year-over-year.
  • Glaukos income taxes for the twelve months ending September 30, 2024 were $0.001B, a 19.21% decline year-over-year.
  • Glaukos annual income taxes for 2023 were $0.001B, a 21.93% increase from 2022.
  • Glaukos annual income taxes for 2022 were $0.001B, a 134.97% increase from 2021.
  • Glaukos annual income taxes for 2021 were $0B, a 102.72% decline from 2020.
Glaukos Annual Income Taxes
(Millions of US $)
2023 $1
2022 $1
2021 $0
2020 $-12
2019 $-65
2018 $1
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
Glaukos Quarterly Income Taxes
(Millions of US $)
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $-0
2022-03-31 $0
2021-12-31 $-0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $-3
2020-09-30 $-1
2020-06-30 $-7
2020-03-31 $-0
2019-12-31 $-66
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $1
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $-0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $-0
2016-09-30 $0
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31 $0
2014-09-30 $0
2014-06-30
2014-03-31 $0
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.951B $0.315B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $194.739B 23.76
Intuitive Surgical (ISRG) United States $191.917B 100.34
Alcon (ALC) Switzerland $42.138B 28.19
Edwards Lifesciences (EW) United States $41.404B 26.29
IQVIA Holdings (IQV) United States $34.726B 19.13
IDEXX Laboratories (IDXX) United States $34.092B 40.15
DexCom (DXCM) United States $29.248B 44.05
STERIS (STE) Ireland $20.926B 24.09
Waters (WAT) United States $20.468B 30.26
SONOVA HOLDING (SONVY) Switzerland $20.297B 0.00
Hologic (HOLX) United States $18.250B 19.26
Fresenius Medical Care AG KGaA (FMS) Germany $12.969B 13.31
Sysmex ADR (SSMXY) Japan $12.688B 39.79
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.100B 89.14
Teleflex (TFX) United States $8.967B 14.30
Masimo (MASI) United States $8.754B 42.36
PROCEPT BioRobotics (PRCT) United States $4.883B 0.00
Integer Holdings (ITGR) United States $4.479B 25.38
Veracyte (VCYT) United States $3.034B 91.05
Inari Medical (NARI) United States $2.984B 0.00
LivaNova (LIVN) United Kingdom $2.789B 16.10
TransMedics (TMDX) United States $2.783B 88.21
Nihon Kohden (NHNKY) Japan $2.293B 17.42
Elekta AB (EKTAY) Sweden $2.192B 17.86
Tandem Diabetes Care (TNDM) United States $1.830B 0.00
RxSight (RXST) United States $1.819B 0.00
Integra LifeSciences Holdings (IART) United States $1.766B 9.23
Alphatec Holdings (ATEC) United States $1.357B 0.00
Artivion (AORT) United States $1.129B 74.81
OPKO Health (OPK) United States $1.106B 0.00
Pulse Biosciences (PLSE) United States $1.048B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.818B 13.91
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.650B 35.10
OrthoPediatrics (KIDS) United States $0.589B 0.00
AxoGen (AXGN) United States $0.561B 0.00
Mesa Laboratories (MLAB) United States $0.542B 12.77
SiBone (SIBN) United States $0.517B 0.00
Treace Medical Concepts (TMCI) United States $0.483B 0.00
Pacific Biosciences Of California (PACB) United States $0.471B 0.00
Tactile Systems Technology (TCMD) United States $0.378B 20.48
Semler Scientific (SMLR) United States $0.337B 22.60
CVRx (CVRX) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.317B 0.00
ClearPoint Neuro (CLPT) United States $0.303B 0.00
NeuroPace (NPCE) United States $0.274B 0.00
AngioDynamics (ANGO) United States $0.273B 0.00
Inogen (INGN) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Nevro (NVRO) United States $0.159B 0.00
KORU Medical Systems (KRMD) United States $0.152B 0.00
Sensus Healthcare (SRTS) United States $0.137B 14.68
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.088B 0.00
LENSAR (LNSR) United States $0.087B 0.00
908 Devices (MASS) United States $0.086B 0.00
Covalon Technologies (CVALF) Canada $0.078B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Neuronetics (STIM) United States $0.023B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00